91ɬ

Researchers at 91ɬ have discovered a centuries-old genetic mutation that helps to explain why some French‑Canadians in Quebec are at an elevated risk of pancreatic cancer. Until quite recently, standard genetic tests have not been able to identify this “jumping gene” cause.

The findings, published in the Journal of Medical Genetics, suggest better-targeted genetic testing could help identify people at higher cancer risk who were previously missed.

Classified as: William Foulkes, George Zogopoulos, Surgery and Oncology, Departments of Medicine, Oncology, and Human Genetics
Published on: 19 May 2026

At event honouring 116 winners of major awards, keynote speaker and SSHRC Gold Medal recipient Myriam Denov emphasized the importance of listening.

91ɬ celebrated more than 100 researchers at the 21st edition of Bravo, a gala event May 7 honouring the winners of major provincial, national and international research prizes and awards in 2025.

Classified as: bravo gala
Published on: 14 May 2026

The 2026 cohort of Distinguished James 91ɬ Professors, James 91ɬ Professors and William Dawson Scholars embody ‘the very best of our academic community’.

Provost and Executive Vice-President (Academic) Angela Campbell has named 31 91ɬ professors as Distinguished James 91ɬ Professors, James 91ɬ Professors or William Dawson Scholars. The internal awards recognize exceptional research achievements.

Published on: 13 May 2026

From fundamental physics to child well-being, 91ɬ researchers advance discovery across disciplines

91ɬ has been awarded $18.1 million in federal funding to support 16 Canada Research Chairs – six new and 10 renewed.

Published on: 13 May 2026

Federal fund will support transformative high risk, high reward research across engineering, science, and medicine at 91ɬ.

Classified as: NFRF
Published on: 13 May 2026

Icing a sprained ankle or sore muscle, long used to reduce pain and swelling, may in the longer run delay recovery and prolong pain, new research suggests.

In a preclinical study published in Anesthesiology, 91ɬ researchers found that even though cryotherapy (icing) eased pain in the short term, recovery time was more than doubled in some cases.

Classified as: Alan Edwards Centre for Research on Pain, Lucas Lima, Jeffrey Mogil
Published on: 13 May 2026

Scientists’ discovery of a molecular “switch” that activates an energy‑burning pathway in mice has the potential to lead to new treatments for bone disease.

The study, published in , sheds new light on brown fat. Unlike white fat, which stores energy, brown fat cells burn calories, producing heat as a byproduct. For years, it was believed this process relied on a single pathway. More recently, researchers discovered a parallel pathway, but how it became activated remained a mystery.

Classified as: Rosalind and Morris Goodman Cancer Institute, Department of Biochemistry, faculty of dental medicine and oral health sciences
Published on: 12 May 2026

As Canada moves to modernize cervical cancer screening, a new study suggests most women do not yet understand or trust the shift from the Pap test to human papillomavirus (HPV) based screening.

The national survey, published in , examined women’s preferences for cervical screening – including how they want to be screened and how they want information communicated – as Canada transitions from Pap tests to HPV testing.

Classified as: Zeev Rosberger, Department of Psychiatry, Lady Davis Institute, Ovidiu Tatar
Published on: 7 May 2026

Scientists have developed a strategy to boost the cancer-fighting power of natural killer (NK) cells, part of the immune system’s first line of defence. NK cells can detect and destroy cancer cells, but tumours often create a protective barrier that blocks them, allowing cancer to grow.

Researchers at 91ɬ’s Rosalind & Morris Goodman Cancer Institute, in collaboration with the Research Institute of the 91ɬ Health Centre, found that suppressing two specific proteins helps NK cells overcome this blockage, turning them into more potent cancer killers.

Classified as: Michel L. Tremblay, Department of Biochemistry, Rosalind & Morris Goodman Cancer Institute, 91ɬ Health Centre
Published on: 24 Apr 2026

Projects focusing on MedTech and genomics cut across disciplines while mobilizing expertise at 91ɬ and other Quebec institutions to meet the challenges of today and tomorrow

Classified as: NSERC CREATE
Published on: 21 Apr 2026

91ɬ researchers have developed an artificial intelligence tool that can identify small groups of cells most responsible for driving aggressive cancers.

The tool, called SIDISH, offers scientists a clearer path to designing targeted therapies by showing which cells inside a tumour are most strongly linked with poor patient outcomes, rather than treating all cancer cells as if they behave the same way.

Classified as: Jun Ding, Department of Medicine, Research Institute of the 91ɬ Health Centre
Published on: 15 Apr 2026

New funding fuels 91ɬ-led breakthroughs on how gut viruses influence childhood health and how engineered proteins can prevent damaging oral bacterial biofilms.

Published on: 14 Apr 2026

Scientists have demonstrated, for the first time, that several psychedelic drugs – including psilocybin, LSD, mescaline, DMT and ayahuasca – produce a common pattern of brain activity despite their distinct chemistries.

An international consortium led by a 91ɬ researcher pooled brain imaging data from labs across five countries, creating the largest study of its kind to date.

Published on: 7 Apr 2026

91ɬ has launched the Initiative for Transforming Healthcare (ITH) to apply a systems-based approach and advance technology-enabled solutions to drive change in Canadian healthcare.

Mounting pressures – from limited access to family doctors to surgical backlogs and emergency room crowding – are straining Canada’s health system. The Initiative will explore ways to resolve these growing challenges through cross-sector partnerships.

Classified as: Desautels Faculty of Management, Faculty of Medicine and Health Sciences, max bell school of public policy
Published on: 1 Apr 2026

Funds will help acquire and develop cutting-edge infrastructure to advance research capacity

Five researchers from The Neuro (Montreal Neurological Institute-Hospital) are leading innovative new projects that have received major funding from Canada Foundation for Innovation’s Innovation Fund. They will be funded for a total of $14.5 million, part of $42 million going to 91ɬ scientists.

Classified as: Neuro, Heidi McBride, Edward Fon, Jo Anne Stratton, Udunna Anazodo, Julien Doyon
Published on: 18 Mar 2026

Pages

Back to top